JOURNAL BACTERIOLOGY, 1993,        p.   2970-2979                                                                 Vol. 175,  10
0021-9193/93/102970-10$02.00/0
Copyright X 1993, American Society Microbiology


          murI Gene Escherichia coli Essential Gene                    Encodes Glutamate Racemase Activity
                         PATRICIA DOUBLET,1 JEAN vAN HEIJENOORT,1 JEAN-PIERRE BOHIN,2
                                      DOMINIQUE MENGIN LECREULX1*
           URA 1131 du Centre National la Recherche Scientifique (CNRS), Biochimie Molkulaire et Cellulaire,
           Universite Paris-Sud, Batiment 432, 91405 Orsay Cedex, UMR 111 du CNRS, Laboratoire Chimie
             Biologique, Universite des Sciences et Technologies Lille, 59655 Villeneuve d'Ascq Cedex2 France
                                           Received 16 December 1992/Accepted 14 March 1993

               murI gene Escherichia coli recently identified basis ability complement             mutant requiring D-glutamic acid growth described date: strain WM335 E. coli B/r (P.
            Doublet, J. van Heienoort, D. Mengin-Lecreulx, J. Bacteriol. 174:5772-5779, 1992). report
            experiments insertional mutagenesis murI gene demonstrate gene essential             biosynthesis D-glutamic acid, specific components cell wall peptidoglycan. special strategy             used construction strains disrupted copy murI, limited capability E. coli
            strains grown rich medium internalize D-glutamic acid. murI gene product overproduced             identified glutamate racemase activity. UDP-N-acetylmuramoyl-L-alanine (UDP-MurNAc-L-Ala),             nucleotide substrate D-glutamic-acid-adding enzyme  murD gene product) catalyzing             subsequent step pathway peptidoglycan synthesis, appears effector racemase activity.

   biosynthesis bacterial cell wall peptidoglycan                 DNA     sequence chromosomal region (6), murI
 (murein) complex process involving different                  gene   product predicted protein 289 amino
cytoplasmic membrane steps (18, 37). Eschenichia                  acids molecular weight 31,500.
coli, D-glutamic acid specific components              previously shown murI gene
peptidoglycan structure. incorporated specifically            capable complementing specific defect strain metabolic pathway addition UDP-N-acetylmu-                WM335 (11).  observation suffi-
ramoyl-L-alanine (UDP-MurNAc-L-Ala), reaction cata-                    cient assess gene product sustain
lyzed D-glutamic-acid-adding enzyme  murD gene                D-glutamic acid synthesis E. coli. genes alanine
product) (28, 35). enzymatic mechanism                      racemases genes D-alanine:D-alanine
D-glutamic acid produced bacteria investigated            ligases, catalyzed reactions metabolic limited number species. different routes                pathway, previously identified E. coli Salmo-
D-glutamic acid biosynthesis identified:   trans-          nella typhimurium (43, 44, 47). report experiments amination process catalyzed D-amino acid transaminase               insertional mutagenesis murI gene demonstrating D-alanine ketoglutarate, demonstrated Ba-               essential biosynthesis D-glutamic acid E.
cillus species (24, 40), (ii) direct conversion L-glu-           coli. special strategy construction strains tamic acid D-glutamic acid catalyzed glutamate                   disrupted copy murI chromosome used,
racemase, observed Lactobacillus Pediococcus                 apparently limited capability E. coli strains
species (33, 34).  attempts identify             D-glutamic acid rich medium. Furthermore, enzymatic activities E. coli present               murI gene product identified glutamate racemase
unsuccessful (11, 22, 33, 40).                                           activity.
   recently investigated problem particular genetics D-glutamic acid biosynthesis E. coli (11). purpose, used known                                  MATERIALS METHODS
mutant requiring D-glutamic acid described date: strain WM335 E. coli B/r (17, 22), resembled                 Bacterial strains, phages, plasmids. E. coli strains previously described mutants defects pepti-                used study listed Table 1. Plasmid pPDM3
doglycan synthesis lytic phenotype exhibited             carrying lamB gene E. coli coding lambda
restrictive growth conditions. particular, identified          receptor cI857 gene codes thermosensitive
gene named murI alteration apparently provoked
                                                                         form lambda repressor previously described (11). auxotrophy D-glutamic acid mutant strain (11).            pUC18, pUC19, pTTQ19 vectors Kanr genblock gene unambiguously mapped 90-min region                originating pUC4K plasmid purchased E. coli chromosome corresponded previously                  Pharmacia, plasmid pBTacl obtained Boehr-
sequenced open reading frame ORFi (6), flanked left               inger. Plasmid pSKS114 (39) used source btuB gene encoding vitamin B12 outer membrane                 cat cartridge. Plasmid pMAK705 (15) bearing thermosen-
receptor protein (1, 16) right rrnB operon             sitive replicon obtained S. R. Kushner Y. genes 16S, 23S, 5S rRNAs (5, 6, 14).                 Mechulam (Laboratoire Biochimie, Ecole Polytechnique,
                                                                         Palaiseau, France). Phage Xdarg13 carrying 20-kb chromo-
                                                                         somal fragment E. coli extending fromppc murI                                                                          previously described (25). Phage clone XE11C11 (clone 534)
  *
      Corresponding author.                                              E. coli miniset library Kohara et al. (20) initially
                                                                  2970
 VOL. 175, 1993                                        murI E. COLI ENCODES GLUTAMATE RACEMASE ACTIVITY                                         2971

                                                   TABLE 1. E. coli strains used study
         Strain                                                Genotype marker                                                Source referencea
E. coli K-12 strains
  JM83                          araA(lac-proAB) rpsL thi +80 dlacZAM15                                                      46
  JM109                         recAl lac-proAB) endAl gyrA96 thiA hsdRl7 supE44 reLA1 (F' traD36                         46
                                  proAB laclqZAM15)
  AB1133                        F- thr-1 leuB6 gpt-proA)62 hisG4 argE3 thi-1 lacYl galK2 ara-14                           2
                                  xyl-5 mtl-1 rpsL-31 supE44
  JC7623                        AB1133 tsx-33 recB21 recC22 sbcB15                                                          45
  NFB366                        JC7623 (X199 Xdarg13)                                                                   work
  FB8                           F- prototroph                                                                               F. Blasi
  JE1011                        F- thr leu trp thy thi lac gal xyl mtl rpsL azi                                         32
  ST5                           JE1011 mrbA (murB)                                                                          B. Bachmann     CGSC 6442
  NK5139                        thi-39::TnlO rrnD-rrnE)1                                                                 B. Bachmann     CGSC 6165
  BW6175                        Hfr X- thr-1 leuB6 azi-15 tonA21 lacYl supE44 argE86::TnlO thi-1                            B. Bachmann     CGSC 6763
  BW6165                        Hfr ara-41, lacYl, lacY40 Xind- xyl-7 mtl-2 argE86::TnlO                                 B. Bachmann     CGSC 6760
  NFB279                        thr-1 leuB6 gpt-proA) 62 hisG4 argE3 thi-1 ara-14 lacYl galK2 xyl-5                       work
                                  mtl-1 btuB202::TnlO rpsL31 supE44
  P180                          MG1655 metA :Cmr                                                                          C. Richaud
  GRA83                         JM83 murI::kan (pMAKI)                                                                      work
E. coli B/r strains
  WM301                         leu pro trp arg thyA deoB met lac gal xyl ara mal lam phx rpsL                          W. Messer PC 2341
                                 hsdS-K12
  WM335                         WM301 glt (murI-335)                                                                        W. Messer PC 2342
  GRA101                        WM335 murI-335 argE86::TnlO                                                                 work
  GRA102                        WM335 murI-335 btuB202::TnlO                                                                work
  GRA103                        WM335 murI-335 thi-39::TnlO                                                                 work
  GRA104                        WM335 murI+ metAA::Cmr                                                                      work
      CGSC, E. coli Genetic Stock Center, Yale University, New Haven, Conn.; PC, Phabagen Collection, Department Molecular Cell Biology, State University Utrecht, Netherlands.


selected complementation D-glutamic-acid-requir-                    amounts isomers glutamic acid estimated ing mutant strain used DNA source                           cell extracts reaction mixtures  assays gluta-
cloning murI gene, previously described (11).                        mate racemase activity  recently developed
   Growth conditions. Unless noted, 2YT (31)                    high-performance liquid chromatography (HPLC) tech-
rich medium M63 (31) supplemented 0.4  glucose                        nique, derivatization aliquots Marfey's chiral defined minimal medium used growing cells.                       reagent. Diastereoisomers L- D-glutamic acid ob-
Growth monitored 600 nm spectrophotometer                        tained reaction 1-fluoro-2,4-dinitrophenyl-5-L-
(model 240; Gilford Instrument Laboratories, , Oberlin,                    alanine-amide described Marfey (23) separated
Ohio). D-Glutamic acid (100 ,ug. ml-'), thymine (100 jig                       HPLC described legend Fig. 5.
ml-'), thiamine (1 ,ug. ml-'), L-amino acids (50 pg                           Isolation sacculi quantitation peptidoglycan. Ex-
ml-1) added case specific strain require-                  ponential-phase cells GRA83 grown 30°C ments. strains carrying drug resistance genes, antibiotics                 30°C 43°C described  Harvested cells used following concentrations  micrograms                       washed cold 0.85  NaCl solution centri- milliliter): ampicillin (100), streptomycin (50), kanamycin                fuged  Bacteria rapidly suspended (30), chloramphenicol (25), tetracycline (15). Broth                   vigorous stirring 40 ml hot (95 100°C) aqueous 4 
plates solidified 1.5  agar, plasmid                         sodium dodecyl sulfate (SDS) solution 30 min. inserts screened absence ot-complementation,                   standing overnight rQom temperature, suspensions
5-bromo-4-chloro-3-indolyl-,3-D-galactopyranoside (X-Gal)                      centrifuged 30 min 200,000 x g, pellets added 40 ,g ml-'.                                                       washed times water. Final suspensions
   Pool levels peptidoglycan precursors. Cells GRA83                     5 ml water homogenized brief sonication.
(1-liter cultures) grown exponentially 30°C 2YT                     Aliquots hydrolyzed analyzed previously 
medium. appropriate cell concentration (3 x 106.                        scribed (26, 30), peptidoglycan content sacculi
ml-'), temperature culture maintained                    expressed terms diaminopimelic acid content. 30°C increased 43°C. Incubation continued                   specific incorporation radioactive meso-diami- optical density culture 43°C reached plateau                   nopimelic acid peptidoglycan lysA derivative
value 0.5 3 h later  Fig. 2). time,                       strain (29) used similar results.
preceding onset cell lysis minutes, cells                    General DNA techniques E. coli cell transformation. rapidly chilled 0°C harvested cold.                    isolation phages extraction purification control, similar cultures strain JM83                           DNAs carried standard techniques (9, 38).
(pMAKI) harboring intact chromosomal copy murI.                          Small- large-scale plasmid isolations carried extraction peptidoglycan precursors analyti-                    alkaline lysis method (38), plasmids eventually
cal procedure used quantitation previously                   purified cesium chloride-ethidium bromide gra-
described (26, 27).                                                            dients. Standard procedures endonuclease digestions,
   Separation isomers glutamic acid. relative                        ligation, filling 5'-protruding ends using Klenow
    2972      DOUBLET ET AL.                                                                                                        J. BACrERIOL.

                         89.5                              90                                              0                                                                                                                         91I   min
                                  argECBH           btuB muri rrnB murB birA            rpoB,C   thi                metA




                                         E    F      BP
                                                                                                                          N       D       HI                                                                                                            
                                             IbtuB      IvnUrIN            PI 1 59 rrsB          II
                                                                                                 -


                                         E    F.       BP
                                                       ..                                                                     N       D       ZUk2JJ pDME
                                                                                  *10.xx                                                    l-    PPDM25
                                                F    N     D
                                             *110\\\\\\\\1]                    pPDM27
                                                  BP N
                                                                               pPDM30
                                                               Kanr


                                                    B       P       r   D
                                                                               p PDM 31
     FIG. 1. Localization murI gene 90-min region E. coli chromosome. Locations genes (3) used   transduction experiments indicated  Bacterial DNAs present phage clone X534 library Kohara et al. (20)   derived plasmid inserts indicated  murI gene represented hatched region, position lac promoter relative
X insert pUC18- pUC19-derived plasmid indicated arrow. Positions cleavage sites shown BstEII (B), DraI
  (D), EcoRI (E), EcoRV (F), HindIII (H), NaeI (N), PstI (P).


  fragment DNA polymerase  agarose electrophoresis                      D-glutamic acid incubated 370C. Growth ob-
  used (38). Usually, E. coli cells competent                     served 24 h incubation.
  transformation plasmid DNA method                              Construction plasmids. DNA phage XE11C11
  scribed Dagert Ehrlich (8), technique                        (clone 534) collection Kohara et al. (20) used
  electroporation preferentially used strain WM335                      starting material construction different
  E. coli B/r transformed.                                                plasmids used study  Fig. 1). Plasmid pPDM25
     Complementation tests D-glutamate auxotrophy.                      carrying 2.5-kb EcoRI chromosomal fragment 
  Adarg13 phage particles. 200-pI volume suspension                    tains murI gene E. coli previously described
  WM335(pPDM3) cells 10 mM MgSO4 incubated 1                          (11). size murI-containing insert reduced   h 30'C shaking lysate containing mixture                   1.3-kb EcoRV-DraI 0.96-kb BstEII-DraI fragments   X199 (carrying cI857 gene) Xdarg13  X199-                         cloned HincII site pUC18 vector   transducing derivative) phage particles (1010. ml-',                      generate plasmids pPDM27 pPDM30, respectively (Fig.
  multiplicity infection 10). addition 400 VA                  1). expression murI control   2YT medium supplemented D-glutamic acid, mix-                         lambda PR promoter, plasmid pPDM33 constructed   ture incubated 30'C shaking additional 2-h                  inserting 2.4-kb XhoII lambda fragment (carrying   period expression phage genes. Cells recovered                     structural gene cI857 encoding thermosensitive form   centrifugation, washed times 2YT medium                     lambda cI repressor, strongpR promoter, Shine-
  remove residual D-glutamic acid, plated 2YT                        Dalgarno sequence cro) unique BamHI site   plates supplemented supplemented D-glutamic                        plasmid pPDM30. Plasmid pPDM34 constructed   acid. Growth observed 24 h incubation 30'C                     inserting initial 2.5-kb EcoRI fragment corre-
  plates lacking D-glutamic acid, clones                        sponding site pTTQ19 vector, orientation
  tested lysogenization lambda phages (thermosensitive                    dependent tac promoter control. cat cartridge
  growth).                                                                       originating plasmid pSKS114 inserted      (ii) Plasmids. WM335 cells competent                        possible orientations unique NaeI site plasmid
  scribed transformed various plasmids                    pPDM34 (lying middle murI gene sequence)   tested. cell suspension (200 pA) mixed DNA                        generate plasmids pPDM35 pPDM36. Similarly, kan
  kept ice 2 h heated 3 min 420C.                     cartridge originating pUC4K inserted    400 pA 2YT medium supplemented D-glutamic                        possible orientations NaeI site plasmid pPDM27,
  acid added, cells incubated 370C 1                    generating pPDM31 pPDM32 (Fig. 1). pMAK~kan
  h expression plasmid genes. Cells recovered                     plasmid obtained insertion 2.5-kb EcoRI-SphI
  centrifugation washed times 2YT medium.                       fragment pPDM31 HindIII site pMAK705
  final suspension 200 p1 2YT medium                            (15). pMAKI plasmid isolated described   separated 2 parts plated 2YT-                         text excision process followed integration   antibiotic plates supplemented supplemented                        pMAKIkan plasmid chromosomal murI locus.  VOL. 175, 1993                                murl E. COLI ENCODES GLUTAMATE RACEMASE ACTIVITY                         2973

construction pTACI2 plasmid carrying murI gene         Bq; Amersham), 0.04 mM UDP-MurNAc-L-Ala, crude control tac promoter diagrammed Fig.       enzyme (30 300 pug protein) final volume 80 jul.
3.                                                                mixtures incubated 370C 1 h, reactions
   Disruption chromosomal murI gene. wild-type         terminated addition 20 pl acetic acid.
chromosomal copy murI gene E. coli strains          Reaction products separated high-voltage electro-
replaced disrupted following alternative          phoresis Whatman 3MM filter paper 2  formic acid
methods.   procedure described Hamilton et al.           (pH 1.9) 45 min 40 V/cm LT36 apparatus
(15), uses pMAK705, plasmid bearing thermosen-          (Savant Instruments, Hicksville, N.Y.), radioactive
sitive replicon, used. pMAK.Ian, pMAK705 deriva-            spots located overnight autoradiography type
tive carrying disrupted murI gene, transformed       R2 films (3M, St. Paul, Minn.) radioactivity scanner
JM83. Integration plasmid chromosome          (model Multi-Tracermaster LB285; Berthold France, Elan-
selected plating cells 440C 2YT plates containing    court, France). radioactive spots (glutamic acid 20 ,ug chloramphenicol ml-'. clones picked        UDP-MurNAc-dipeptide) cut counted  integration pMAKIkan murI locus         Intertechnique SL 30 liquid scintillation spectrophotometer
verified Southern analysis (data shown). plasmid       solvent consisting 2 ml water 13 ml excised chromosome follows. Cointe-          Aqualyte mixture (J. T. Baker Chemicals, Deventer, grants grown 300C 2YT-chloramphenicol           Netherlands). verified [D-14C]glutamic acid 30 doubling times subsequently plated           cases quantitatively converted nucleotide
30'C. Individual clones screened sensitivity     form D-glutamic-acid-adding activity. (ii) direct
chloramphenicol 440C, indicative plasmid           assay, UDP-MurNAc-L-Ala ATP-Mg + omitted
excision. structures excised plasmids         reaction mixture, ratio L- D-isomer eral clones determined DNA restriction analysis.          glutamic acid determined HPLC procedure clone containing plasmid bearing wild-type murI         described 
gene (called pMAKI) chosen. Finally, replacement strain (named GRA83) chromosomal murI copy                                    RESULTS inactivated verified Southern analysis
(data shown). (ii) procedure described Winans et         Attempts transduce murI mutation bacterial strains
al. (45) used. Plasmid pPDM35 pPDM36 harboring           D-glutamic-acid-requiring mutant strain
disrupted copy murI gene  cat cartridge)          WM335. murI gene E. coli, required linearized BamHI used transform strain JC7623,        biosynthesis D-glutamic acid, recently identified recB recC sbcB strain transformed linear         90-min region chromosome (11). function DNA (45). Exchange mutated copy murI           apparently altered auxotrophic mutant described
chromosomal wild-type gene selected plating         date, strain WM335 E. coli B/r (17, 22). tried transformed bacteria 2YT plates presence             transduce mutation (named murI-335) E. coli K-12.
chloramphenicol D-glutamic acid.                              using argE, btuB, thi markers     Preparation crude enzyme. Cells JM109(pBTacl)          TnlO transposon inserted), chosen high frequencies JM109(pTACI2) (constructs diagrammed Fig. 3)          cotransduction wild-type murI+ gene (35, 95, grown exponentially (1-liter cultures, duplicate) 370C   75 , respectively). case, clones WM335 LB medium (31) supplemented ampicillin.             acquired tetracycline resistance remained auxotrophic
optical density cultures reached 0.1, isopropyl-13-D-      D-glutamic acid isolated (strains GRA101 thiogalactopyranoside (IPTG) added cul-         GRA103). P1 phage lysates produced strains tures final concentration 1 mM, growth            used transduce TnlO transposon prototro-
continued 3 h. Cells harvested cold           phic strain, FB8, E. coli K-12. Transductants washed 40 ml cold 0.02 M potassium phosphate              selected 2YT plates supplemented tetracycline buffer (pH 7) containing 0.1  3-mercaptoethanol (standard         D-glutamic acid. Surprisingly, isolated argE::TnlO,
buffer). wet cell pellet (ca. 1.5 g) suspended 12 ml   btuB::TnlO, thi::TnlO clones  300 buffer disrupted sonication (Sonicator         case) appeared prototrophic D-glutamic acid. 150; T. S. Ultrasons, Annemasse, France) 10 min          unexpected finding difference B
cooling. resulting suspension centrifuged 40C      K-12 species organization genes 30 min 200,000 x g Beckman TL100 centrifuge.        region chromosome, observed supernatant eventually dialyzed overnight 40C      parental strain WM301 E. coli B/r used 100 volumes standard buffer, resulting solution    recipient strain. verified phage stocks carried
(300 mg protein 11 ml), designated crude enzyme,       murI-335 allele. Strain WM335 converted stored -20'C. SDS-polyacrylamide gel electrophore-         prototrophy acquisition murI+ gene, sis (PAGE) analysis proteins crude        cotransduced case 25  met4::Cm marker.
extracts performed previously described (21)           observed clone (GRA104) returned
13  polyacrylamide gels.                                          initial auxotrophic status transduced Tetr    Enzymatic assays. Glutamate racemase activity crude         phage stocks Tetr murI-335 described 
enzyme preparations determined different pro-            results interpreted ways.   cedures.   coupled assay, D-glutamic acid pro-       murl mutation effectively transferred ge-
duced L-isomer glutamate racemase              netic backgrounds, effect D-glutamic acid
converted UDP-MurNAc-L-Ala-D-Glu D-glutam-              biosynthesis, result indicative presence ic-acid-adding enzyme present high level activity    gene E. coli chromosome compensating murI crude extracts (30, 35). standard assay mixture            mutation.  hypothesis unlikely, contained 0.1 M Tris-hydrochloride buffer (pH 8.6), 20 mM         previous experiments complementation WM335
MgCl2, 10 mM ATP, 0.02 mM [L-14C]glutamic acid (100,000           defect various DNA sources allowed identify  2974     DOUBLET ET AL.                                                                                                J. BACT1ERIOL.
 murI gene. (ii) murI mutation trans-             L-glutamic acid particular permease encoded ferred strains WM335 mutant, probably            gltS gene previously shown transport result additional mutation strain     D-isomer (10, 19, 42).
prerequisite isolation mutants altered murI             Inactivation chromosomal murI gene effect gene. second hypothesis corroborated studying             peptidoglycan metabolism. inactivate murI gene cotransduction frequencies markers equidistant           chromosome, used procedure described region (Fig. 1): argE, murI, murB, codes          Hamilton et al. (15) particularly adapted UDP-GlcNAc-enolpyruvate reductase (12, 36).                 case essential genes.  murI gene-coding se-
thermosensitive ST5 strain E. coli K-12 (32) altered        quence carried pPDM27 plasmid disrupted murB gene transduced tetracycline resistance                insertion NaeI site 1.24-kb kanamycin resis-
using different phage stocks: specifying argE::TnlO           tance gene pUC4K, generating plasmid pPDM31 (Fig.
murI+ murB+ specifying argE::TnlO murI-335                    1).  total insert pPDM31 plasmid murB+. Arginine-requiring clones selected 30'C             inserted pMAK705 vector bears thermosen-
2YT plates supplemented tetracycline D-glutamic              sitive replicon. resulting plasmid, pMAKLkan, used
acid. case, 30  Tetr ST5                 described Materials Methods construction derivatives isolated thermoresistant (murB+),             strain derived JM83, GRA83 (JM83 murI::kan Tetr clones selected experiment              [pMAKI]), having inactivated murI gene chromo- grow 420C, result suggesting impossible        wild-type allele pMAK705 vector. transfer murB+ gene mutated copy            nonpermissive temperature plasmid replication (43 murI gene.                                                        440C), GRA83 failed grow 2YT plates, indicating    second mutation present strain WM335               strain disrupted copy murI gene essential isolation murI mutation. confirm        chromosome viable presence trans involvement sole murI gene synthesis                 plasmid carrying murI+ gene. control, GRA83 D-glutamic acid E. coli, tried inactivate gene       infected P1 transduction strains having chromosome using procedure described Win-               (JC7623) (NFB366 [JC7623 Xdargl3J) copies ans et al. (45). Cartridges expressing resistance chloram-         murI gene. selected marker Kanr, phenicol kanamycin inserted various murI-                strain copies murI yielded transductants, carrying plasmids NaeI site located middle                did high frequency, result confirming murI position sequence. resulting plasmids           essential gene.
disrupted copy murI linearized enzymes                 plasmid pMAKI bears thermosensitive repli-
cut polylinker vectors used             effects inactivation murI gene transform strain JC7623 E. coli K-12, recB recC sbcB             observed shifting cultures GRA83 cells growing 30°C
strain transformed linear DNA (45).         2YT medium nonpermissive temperature 43°C. Cmr Kanr clones selected presence D-glu-             shown Fig. 2A, cells grew normally 43°C tamic acid fact ampicillin resistant            3 h rapidly lysed. delay preceding cell lysis
contained original intact plasmid. method,              9 generation times) corresponds time needed unable exchange chromosomal copy murI              copies pMAKI plasmid cured,
gene disrupted  lengths                followed time preexisting MurI molecules homologous DNAs present plasmids sides               progressively diluted remaining internal pool inserted cartridge spite presence high      D-glutamic acid consumed. demonstrate concentration D-glutamic acid growth medium.                lysis occurred result depletion pool    results experiments described              D-glutamic acid, cells harvested just onset altered murI gene strain WM335 untrans-             cell lysis, contents peptidoglycan nucleotide
ferable E. coli strains chromosomal             precursors estimated. previously shown murI gene disrupted affecting cell               WM335 mutant deprived D-glutamic acid (11), GRA83
viability, D-glutamic acid present high             cells accumulated 43°C large amounts UDP-MurNAc-
concentration growth medium. suggested                L-Ala, pools precursors located downstream presence strain WM335 second mutation                pathway progressively depleted (data shown).
essential expression phenotype requiring D-glu-          result, cell lysis observed cell peptidogly-
tamic acid. likely hypothesis wild-type E.          content reduced critical value representing 70 
coli strains did efficiently internalize D-glutamic acid,         normal cell content. e., rate sufficient fulfill specific require-      Furthermore, D-glutamic acid shown restore ments peptidoglycan synthesis. Transductants ac-              normal phenotype GRA83 cells 43°C growth quired disrupted copy murI gene chromosome            performed minimal medium (Fig. 2B). result probably lysed expression period, spite          indicated uptake D-amino acid wild-type
presence D-amino acid growth medium.                    strains blocked complex growth media    observed labeled [DL-14C]glutamic acid inter-          used. finally proved phenomenon related
nalized poorly WM335 WM301 strains                   presence rich medium high concentration added exponential-phase cells growing rich                 L-glutamic acid competes D-isomer medium (data shown).  slightly higher rate           permease (data shown).
uptake observed mutant cells. probably                   Overproduction murI gene product. Previous 
explains capability D-amino acid complement             tempts determine biochemical mechanism murI defect strain. aim             murI gene product synthesizes D-glutamic acid E. coli
present study analyze additional muta-          unsuccessful (11, 22, 33, 40). overproduc-
tion increased uptake D-glutamic acid strain           tion murI gene product considered WM335. Likely candidates permeases specific               prerequisite facilitated identification activity.
 VOL. 175, 1993                                   murl E. COLI ENCODES GLUTAMATE RACEMASE ACITIVITY                                 2975




                           305
                            0j




                             0.01-




                                         2        4        6   h
                                                                 hours               4         8         12
  FIG. 2. Effect inactivation murI gene growth E. coli K-12. GRA83 cells grown exponentially 30'C 2YT   minimal medium supplemented 0.4  glucose (B). time indicated arrow, temperature culture maintained 30'C shifted 430C. Symbols: *, growth 300C absence D-glutamic acid; 0, growth 43'C presence D-glutamic acid; 0, growth 43'C absence D-glutamic acid. O.D., optical density.

                                                                                     EcoRl                             PstI
   purpose, plasmids expressing gene                      5' P-AATTCATGAGACAGTCTATGGCTACCAAACTGCA 3'
                                                                                 3'        GTACTCTGTCAGATACCGATGGTTTG-P     5'
control strong promoters constructed. plas-
mid, pPDM33, contained BstEII-DraI fragment ex-
pressed control lambda PR promoter.  exponentially growing cells JM83
(pPDM33) shifted 420C  derepression PR                                                             P   N       D     H
promoter), overproduction protein detected                                                             Lour SDS-PAGE analysis corresponding extracts. Baliko
et al. (4) previously tried determine biological function gene, supposed related downstream rrnB
operon rRNA genes (5, 14). particular, reported attempts achieve significant overproduction protein merely exchanging promoter ORFi
gene  murl gene) stronger promoter  case, P2 promoter rmB) failed completely, suc-
ceeded constructing overproducing plasmid exploiting principle translational coupling (4).
   constructed plasmid expressing murI gene
directly control strong tac promoter (Fig. 3). construct, chromosomal DNA sequence
preceding ATG initiation codon eliminated. took
advantage fact unique PstI site lies gene sequence 25 bp putative start codon
(Fig. 1). 1.3-kb PstI-HindIII fragment contains truncated murI gene purified ligated pBTacl
vector (cut EcoRI HindIII), presence synthetic phosphorylated double-strand linker correspond-
ing beginning gene  ATG initiation
codon PstI site) preceded EcoRI site (Fig. 3).               FIG. 3. Construction plasmid pTACI2. 1.3-kb PstI- D-glutamic-acid-requiring strain WM355 trans-                  HindIII fragment contains murI gene truncated 25
formed ligation mixture electroporation.               bases ligated pBTacl vector cut EcoRI HindIII                                                                        presence phosphorylated synthetic oligonucleotides
selecting directly complementation, isolated 25 clones          sequences shown  hybridized  carried expected plasmid, called pTACI2 (Fig. 3).         oligonucleotides reconstitute 5' end gene,    Recombination-deficient strain JM109 carrying copy              initiation codon (underlined) PstI site, preceded EcoRI lacPq repressor gene F' transformed             site. Positions cleavage sites indicated BamHI (B), DraI plasmid. Exponential-phase JM109 cells harboring             (D), EcoRI (E), HindIII (H), NaeI (N), PstI (P), SmaI (S).
 2976     DOUBLET ET AL.                                                                                                  J. BACTERIOL.

                 MW     B C D                      MW
                                                                        assay D-glutamic acid produced                                                                         L-isomer converted UDP-MurNAc-L-Ala-D-Glu,
                                                                        taking advantage activity D-glutamic-acid-
                                                                        adding enzyme present extracts. procedure
          94                                                            allowed detect high level glutamate racemase
                                                                        activity extracts strain JM1O9(pTACI2), compared
                                                                        practically undetectable level extracts strain
          67                                                            JM109(pBTacl) wild-type strains previously inves-
                                                                        tigated (11). specific activities glutamate racemase                                                                          nanomoles UDP-MurNAc-L-Ala-[D-14C]Glu synthesized
                                                                        hour milligram protein) follows crude
                                                                        extracts cells grown LB medium: JM1O9(pBTac1)
         43                                                             IPTG, 0.02; JM109(pTACI2) IPTG,
                                                                        3.8 (overproduction factor, 190); JM1O9(pTACI2)                                                                         IPTG, 4.6 (overproduction factor, 230). Evidence                                                                         [D-14C]glutamic acid synthesized direct racemization
                                                                        L-isomer action D-alanine:D-
                                                                        glutamic acid transaminase provided different exper-
          30                                                            iments.   racemase activity detected                                                                         extensive dialysis extract eliminated cosub-
                                                                        strates putative transaminase activities. noted
                                                                        dialysis accompanied significant loss race-
                                                                        mase activity  50 ), verified                                                                         related instability enzyme loss
                                                                        eventual cofactors substrates. (ii) Addition keto-
          20                                                            glutarate (1 mM) reaction mixture did significantly
                                                                        affect transfer radioactivity isomers glu-
   FIG. 4. Overproduction 31K (31,000-molecular-weight) pro-       tamic acid, result indicating clearly ketoglutarate
tein crude extracts strain JM109(pTACI2). Strains JM109         intermediate process. (iii) Addition (pTACI2) JM109 harboring control vector pBTacl does        D-cycloserine (1 mM) slightly inhibited reaction, contain murI gene grown exponentially 370C           previously shown D-alanine:D-gluta-
LB-ampicillin medium. necessary, IPTG added 1 mM          mate transaminase Bacillus species (24) final concentration optical density culture reached
0.1. Cells harvested 3 h later disrupted sonication.   enzymes D-alanine substrate completely inhib- described Materials Methods, protein contents      ited micromolar concentrations antibiotic.
soluble particulate fractions obtained high-speed centrifu-      direct assay carried UDP-
gation corresponding crude extracts analyzed SDS-        MurNAc-L-Ala, [D- 4C]glutamic acid detectable PAGE. Molecular weight (MW) standards  thousands) indicated          HPLC analysis. reaction mixture devoid ATP left follows: phosphorylase b (94), bovine serum          Mg2", required conversion D-glu-
albumin (67), ovalbumin (43), carbonic anhydrase (30), soybean      tamic acid nucleotide UDP-MurNAc-L-Ala-D-Glu.
trypsin inhibitor (20). Lanes: B, analysis soluble         hypothesized D-glutamic acid good
fractions JM109(pBTacl) cells grown absence       substrate racemase, Km value lower presence IPTG, respectively; C D, analysis soluble
fractions JM109(pTACI2) cells grown absence       L-isomer, implying molecule D-glutamic acid
presence IPTG, respectively. 31K protein corresponding        produced assay rapidly reused murI gene product, highly overproduced extract          reverse synthesis L-isomer, immediately incor-
strain JM109(pTACI2), indicated arrow right.      porated nucleotide precursor. presence band completely absent corresponding particulate frac-       low concentrations UDP-MurNAc-L-Ala (5 ,uM), tions (data shown).                                                 30  radioactivity L-glutamic acid                                                                         recovered D-isomer form. effect specific,
                                                                        nucleotide precursor UDP-GlcNAc plasmid overproduced relatively high levels murI            UDP-MurNAc-pentapeptide effector added gene   product (Fig. 4), detected SDS-PAGE band                 0.1 mM. purification glutamate racemase migrating 31- 32-kDa species, finding agreement            required determine kinetic parameters forward value 31,500 calculated DNA sequence               reverse reactions catalyzed enzyme (6). band detected exclusively soluble                  investigate UDP-MurNAc-L-Ala effect 
fraction extract. high-level overproduction                Effects overproduction glutamate racemase protein observed absence IPTG (Fig.               pool D-glutamic acid. overexpression glutamate
4), probably single copy lacIq did produce             racemase activity JM109(pTACI2) cells ap- repressor molecules efficiently repress tran-             parent effect cell growth bacterial shape. 
scription murI gene high-copy-number                   sumed overproduction enzymatic activity plasmid.                                                                cell content resulted modification    Identification murI gene product glutamate               pool levels isomers glutamic acid. effec-
racemase activity. apparent overproduction murI              tively observed pool glutamic acid (L plus D) gene product prompted assay corresponding enzy-               cells growing exponentially 2YT medium significantly
matic extracts glutamate racemase D-amino acid                  increased presence plasmid  19,000 transaminase activities. detect eventual racemase                 27,000 nmol expressed g bacterial dry weight).
activity crude extracts, used convenient coupled           D-isomer, normally represents small
 VOL. 175, 1993                                     murl E. COLI ENCODES GLUTAMATE RACEMASE ACTIVITY                          2977

                                                                        D-glutamic acid growth described date:
                                                                        strain WM335 E. coli B/r (17, 22). altered gene,
                                                                        named murI, identified previously sequenced open
                                                                        reading frame, ORFi (6), lying 90-min region                                                                         chromosome, btuB gene encoding vitamin
                                                                        B12 receptor protein (16) rrsB gene coding 16S
                                                                        rRNA (6). noteworthy btuB murI genes
                                                                        considerable 65-bp overlap (1, 6). Interestingly,
                                                                        mutations affecting peptidoglycan metabolism                                                                         earlier located region chromosome near argH
 2                                                                      (32, 41), consequently named mrb, murein
                                                                        region b, including, particular, mutation conferring
                                                                        resistance fosfomycin (41), interpreted                                                                         alteration murA gene coding PEP:UDP-GlcNAc-
                                                                        enolpyruvyl transferase, mutation characterized
                                                                        thermosensitive lytic phenotype accumulation
                                                                        pool UDP-GlcNAc-enolpyruvate restrictive
                                                                        growth temperature (strain ST5 reference 32).      Ci                                                                 case, corresponding altered gene murB encodes                                                                         UDP-GlcNAc-enolpyruvate reductase recently identi-
                                                                        fied (12, 36), 6 kb clockwise respect murI gene,
                                                                        rrnB operon birA gene required                                                                         biotin synthesis (Fig. 1). cellular functions                                                                         genes particular region btuB rpoBC                                                                         established. murA gene identi-
                                                                        fied date, clear murA, murB,                                                                         murI genes belong cluster tightly packed genes
                                                                        related functions case mur genes
                                                                        2-min region E. coli chromosome (28).
                                                                           murI gene E. coli gene selected
                                                                        complementation specific defect strain WM335.
          0                 10                   20                     Evidence provided essential gene                                                                         inactivation results D-glutamic acid auxotrophy.                                   minutes                               able construct strain, GRA83, chromosomal
   FIG. 5. Separation L- D-isomers (L D, respectively)    murI gene disrupted viable presence glutamic acid HPLC derivatization Marfey's reagent.       plasmid carrying wild-type gene. plasmid
Diastereoisomers obtained reaction 1-fluoro-2,4-dinitro-     bears thermosensitive replicon, effects inactiva-
phenyl-5-L-alanine amide separated HPLC LiChro-            tion easily visualized shifting exponentially growing
spher 100CH 18/2 column (Merck). Elution 12 mM                 cells nonpermissive temperature. Cells shown ammonium phosphate (pH 5.6) containing 10  acetonitrile.            accumulate UDP-MurNAc-L-Ala pools nucle-
flow rate 1 ml. mink, column temperature 370C.          otide precursors located downstream pathway Elution monitored 340 nm sensitivity 0.04 absorbance
units  scale).   Analysis standard mixture containing 0.5   rapidly depleted. result, peptidoglycan synthesis nmol isomer glutamic acid; (b c) analysis      inhibited cell lysis finally occurred, previously ob- conditions pool free glutamic acid isolated         served initial WM335 mutant depleted JM109(pBTacl) JM109(pTACI2) cells, respectively. O.D., op-          D-glutamic acid (11). clear inactivation tical density.                                                           sole murI gene sufficient expression D-glutamic-
                                                                         acid-requiring phenotype.
                                                                           Furthermore, data possible percentage (3  case) pool, detected              transduce altered murI gene WM335 20  total glutamic acid (Fig. 5).                    GRA83 species genetic backgrounds, spite                                                                          presence high concentration D-glutamic acid                         DISCUSSION                                       growth medium. strains harboring copies                                                                         murI gene efficient recipients experiments.
  D-Glutamic acid essential component bacterial cell            reason discrepancy wild-type E. coli
wall peptidoglycan practically exclusively encoun-                strains poorly D-glutamic acid, e., rate
tered  Identification enzymatic process                apparently sufficient fulfill specific D-amino acid synthesized bacteria              requirements peptidoglycan synthesis. D-glu-
fore greatest  considered            tamic acid unable complement murl defect potential target search new antibacterial com-                GRA83 cells growing 430C rich medium, longer
pounds. early studies, biosynthesis D-glutamic acid            failed minimal medium. investigated Bacillus, Lactobacillus, Pediococ-               absence synthetic minimal medium compounds cus species, little attention paid             L-glutamic acid compete D-glutamic acid
problem enteric bacteria E. coli medi-              permeation  control, shown cally important bacterial species.                                       murI defect transduced genetic 
  genetics D-glutamic acid biosynthesis E. coli            ground chosen, soon transductants selected recently investigated mutant requiring           minimal medium supplemented D-glutamic acid.  2978       DOUBLET ET AL.                                                                                                J. BACTERIOL.

results confirmed assumption original                              ACKNOWLEDGMENTS
WM335 mutant, initially selected rich medium,            thank B. Bachmann supplying E. coli strains
necessarily carries additional mutation specific glu-      used work R. Aufrere helpful discussions.
tamate permease gene. Recently, Dougherty et al. (13)                 work supported grants Centre National la
sequenced gltS gene strain WM335 showed          Recherche Scientifique (URA 1131) Institut National la
                                                                   Sante et la Recherche Medicale (900314). P. Doublet effectively altered missense mutations.          supported scholarship Ministere la Recherche et isolation double mutant unfavorable,       la Technologie. explain known D-glutam-
ic-acid-requiring strain described date.                                      REFERENCES
   Attempts detect glutamate racemase              1. Aufrere, R., M. Tempite, J.-P. Bohin. 1986. cas                                                                        chevauchement cadres lecture chez Eschenchia coli. C.R.
D-alanine:D-glutamate transaminase wild-type E. coli                Acad. Sci. 303:49-54.
strains previously met failure (11, 22, 33, 40).    2. Bachmann, B. J. 1972. Pedigrees mutant strains assumed enzyme probably expressed                Escherichia coli K-12. Bacteriol. Rev. 36:525-557. low level E. coli cells, confirmed data     3. Bachmann, B. J. 1983. Linkage map Escherichia coli K-12, Baliko et al. (4) showed ORFi-encoded              edition 7. Microbiol. Rev. 47:180-230.
protein observed limit detectability cells       4. Baliko, G.,  Raukas,  Boros, P. Venetianer. 1988. labeled [L-35S]methionine. Evidence provided
                                                                       Escherichia coli gene search function. Mol. Gen. Genet.
                                                                       211:326-331. present study murI gene encodes glutamate         5. Boros, ,  Kiss, B. Sain, G. Somlyai, P. Venetianer. 1983.
racemase activity. possible constructing              Cloning promoters Escherichia coli rRNA gene.
strains overproduce murI gene product high               New experimental study regulation rRNA
level developing efficient sensitive assay           transcription. Gene 22:191-201. glutamate racemase activity. enzyme             6. Brosius, J., T. J. Dull, D. D. Sleeter, H. F. Noller. 1981.
greatly unstable, overnight dialysis crude extract        Gene organization primary structure ribosomal RNA
                                                                       operon Escherichia coli. J. Mol. Biol. 148:107-127. accompanied important loss activity.         7. Choi, S.-Y., N. Esaki, T. Yoshimura, K. Soda. 1991. purification steps glutamate racemase Pedi-            Overproduction glutamate racemase Pediococcuspentosa-
ococcuspentosaceus, Soda coworkers (7, 33, 34) used              ceus Escherichia coli clone cells purification. Prot.
standard buffer containing 1 mM DL-glutamic acid, 10                   Expression Purification 2:90-93.
glycerol, 0.1  P-mercaptoethanol stabilization       8. Dagert, M., S. D. Ehrlich. 1979. Prolonged incubation enzymatic activity. authors recently reported (7)           calcium chloride improves competence Escherichia coli glutamate racemase P. pentosaceus composed              cells. Gene 6:23-28.
                                                                    9. Davis, R. W., D. Botstein, J. R. Roth. 1972. Advanced
265 amino acids molecular weight 29,140.           bacterial genetics. Cold Spring Harbor Laboratory, Cold Spring noted values similar calcn-            Harbor, N.Y.
lated E. coli murI gene product. search          10. Deguchi, Y.,  Yamato, Y. Anraku. 1989. Molecular cloning
eventual homology amino acid sequences                  gltS gltP, encode glutamate carriers Escherichia racemase species required DNA sequence                 coli B. J. Bacteriol. 171:1314-1319.
Pediococcus gene, published date.            11. Doublet, P., J. van Heijenoort, D. Mengin-Lecreulx. 1992.
   D-Glutamic acid specific component peptidogly-          Identification Eschenchia coli murI gene,                                                                        required biosynthesis D-glutamic acid, specific structure, macromolecule normally accounts                                                                        component bacterial peptidoglycan. J. Bacteriol. 174:5772-
1 2  dry cell weight (30). minor cellular          5779.
utilization compared L-isomer, important       12. Doublet, P., J. van Heiienoort, D. Mengin-Lecreulx. 1992.
metabolite used pathways particular               Identification murI murB genes coding cytoplasmic
protein synthesis. pool level D-glutamic acid         peptidoglycan synthetases 90-min region E. coli low compared L-isomer,             chromosome, p. 139-146. M.  Pedro, J. V. Holtje, case cells overproducing glutamate racemase activity.           W. Loffelhardt (ed.), Bacterial growth lysis: metabolism tempting imagine physiological mechanism              structure bacterial sacculus. Plenum Publishing
                                                                       Company, London.
exists controls activity glutamate racemase     13. Dougherty, T. J., J.  Thanassi, M. J. Pucci. 1993. avoid excessive conversion L-glutamic acid                Escherichia coli mutant requiring D-glutamic acid result D-isomer. adjustment synthesis D-glutamic acid            mutations distinct genetic loci. J. Bacteriol. 175:111-116. requirements peptidoglycan synthesis,             14. Erdei, S.,  Boros, G. Szabo, P. Venetianer. 1983. novel
particular flow UDP-MurNAc derivatives            type bacterial transcription unit, specifying mRNA, rRNA,
main reaction sequence pathway,                  tRNA. Mol. Gen. Genet. 191:162-164.
considered. fact, activity glutamate racemase        15. Hamilton, C. M., M. Aldea, B. K. Washburn, P. Babitzke,                                                                        S. R. Kushner. 1989. New method generating deletions detectable direct-assay conditions UDP-
                                                                       gene replacements Escherichia coli. J. Bacteriol. 171:4617-
MurNAc-L-Ala added reaction mixture.               4622.
ingly, effect specific nucleotide,       16. Heller, K., R. J. Kadner. 1985. Nucleotide sequence precursor UDP-GlcNAc UDP-MurNAc-pen-                     gene vitamin B12 receptor protein outer membrane
tapeptide effector. result important,         Escherichia coli. J. Bacteriol. 161:904-908. suggests activity glutamate racemase      17. Hoffman, B., W. Messer, U. Schwarz. 1972. Regulation modulated vivo concentration           polar cap formation life cycle Escherichia coli. J.
substrate D-glutamic-acid-adding enzyme cata-             Supramol. Struct. 1:29-37.
                                                                   18. Holtje, J. V., U. Schwarz. 1985. Biosynthesis growth lyzes subsequent step pathway peptidoglycan             murein sacculus, p. 77-119. N. Nanninga (ed.), Molecular
synthesis. purification enzyme progress              cytology Escherichia coli. Academic Press, , New York.
control phenomena observed crude enzyme prepa-            19. Kalman, M., D. R. Gentry, M. Cashel. 1991. Characteriza-
rations.                                                               tion Escherichia coli K12 gltS glutamate permease gene.
 VOL. 175, 1993                                     murl E. COLI ENCODES GLUTAMATE RACEMASE ACTIVITY                                  2979

     Mol. Gen. Genet. 225:379-386.                                            characterization enzyme Pediococcus pen-
20. Kohara, Y., K. Akiyama, K. Isono. 1987. physical map              tosaceus. Agric. Biol. Chem. 52:3099-3104.
     E. coli chromosome: application new strategy      35. Pratviel-Sosa, F., D. Mengin-Lecreulx, J. van HeUenoort.
     rapid analysis sorting large genomic library. Cell          1991. Overproduction, purification properties uridine
     50:495-508.                                                              diphosphate N-acetylmuramoyl-L-alanine:D-glutamate ligase
21. Laemmli, U. K., M. Favre. 1973. Maturation head             Escherichia coli. Eur. J. Biochem. 202:1169-1176.
     bacteriophage T4. J. Mol. Biol. 80:575-599.                         36. Pucci, M. J., L. F. Discotto, T. J. Dougherty. 1992. Cloning
22. Lugtenberg, E. J. J., H. J. W. Wjsman, D. van Zaane. 1973.            identification Escherichia coli murB DNA sequence,
     Properties D-glutamic acid-requiring mutant Escherichia          encodes UDP-N-acetylenolpyruvoyl-glucosamine reduc-
     coli. J. Bacteriol. 114:499-506.                                         tase. J. Bacteriol. 174:1690-1693.
23. Marfey, P. 1984. Determination D-amino acids. II. Use        37. Rogers, H. J., H. R. Perkins, J. B. Ward. 1980. Biosynthesis
     bifunctional reagent, 1,5-difluoro-2,4-dinitrobenzene. Carlsberg         peptidoglycan, p. 239-297. Microbial cell walls mem-
     Res. Commun. 49:591-596.                                                 branes. Chapman & Hall, , London.
24. Martinez-Carrion, M., W. T. Jenkins. 1965. D-Alanine-D-          38. Sambrook, J., E. F. Fritsch, T. Maniatis. 1989. Molecular
     glutamate transaminase. II. Inhibitors mechanism              cloning: laboratory manual, 2nd ed. Cold Spring Harbor
     transamination D-amino acids. J. Biol. Chem. 240:3547-3552.           Laboratory, Cold Spring Harbor, N.Y.
25. Mazaitis,  J., S. Palchaudhuri, N. Glansdorff, W. K.           39. Shapira, S. K., J. Chou, F. V. Richand, M. J. Casadaban.
     Maas. 1976. Isolation characterization XdargECBH trans-           1983. New versatile plasmid vectors expression hybrid
     ducing phages heteroduplex analysis argECBH                   proteins coded cloned gene fused lacZ gene sequences
     cluster. Mol. Gen. Genet. 143:185-196.                                   encoding enzymatically active carboxy-terminal portion 26. Mengin-Lecreulx, D., B. Flouret, J. van HeUenoort. 1982.
     Cytoplasmic steps peptidoglycan synthesis Escherichia              0-galactosidase. Gene 25:71-82.
     coli. J. Bacteriol. 151:1109-1117.                                  40. Tanizawa, K., S. Asano, Y. Masu, S. Kuramitsu, H. Kag-
27. Mengin-Lecreulx, D., B. Flouret, J. van Heuenoort. 1983.              amiyama, H. Tanaka, K. Soda. 1989. primary structure
     Pool levels UDP-N-acetylglucosamine UDP-N-acetylglu-              thermostable D-amino acid aminotransferase thermo-
     cosamine-enolpyruvate Escherichia coli correlation           philic Bacillus species correlation L-amino acid
     peptidoglycan synthesis. J. Bacteriol. 154:1284-1290.                    aminotransferases. J. Biol. Chem. 264:2450-2454.
28. Mengin-Lecreulx, D., C. Parquet, L. R. Desviat, J. Pla, B.           41. Venkateswaran, P. S., H. C. Wu. 1972. Isolation      Flouret, J.  Ayala, J. van Heijenoort. 1989. Organization          characterization phosphonomycin-resistant mutant Esch-
     murE-murG region Escherrchia coli: identification           erichia coli K-12. J. Bacteriol. 110:935-944.
     murD gene encoding D-glutamic-acid-adding enzyme. J.        42. Wallace, B., Y.-J. Yang, J. Hong, D. Lum. 1990. Cloning
     Bacteriol. 171:6126-6134.                                                sequencing gene encoding glutamate aspartate
29. Mengin-Lecreulx, D., E. Siegel, J. van Heienoort. 1989.               carrier Escherichia coli K-12. J. Bacteriol. 172:3214-3220.
     Variations UDP-N-acetylglucosamine UDP-N-acetyl-             43. Wasserman, S. , C. T. Walsh, D. Botstein. 1983.      muramyl-pentapeptide pools Escherichia coli inhibition          alanine racemase genes Salmonella typhimunium differ      protein synthesis. J. Bacteriol. 171:3282-3287.                       structure function. J. Bacteriol. 153:1439-1450.
30. Mengin-Lecreulx, D., J. van Heienoort. 1985. Effect           44. Wild, J., J. Hennig, M. Lobocka, W. Walczak, T. Klopo-
     growth conditions peptidoglycan content cytoplasmic               towski. 1985. Identification dadX gene coding      steps biosynthesis Escherichia coli. J. Bacteriol. 163:        predominant isozyme alanine racemase Eschenichia coli
     208-212.                                                                 K12. Mol. Gen. Genet. 198:315-322.
31. Miller, J. H. 1972. Experiments molecular genetics. Cold          45. Winans, S. T., S. J. Elledge, J. H. Krueger, G. C. Walker.
      Spring Harbor Laboratory, Cold Spring Harbor, N.Y.                       1985. Site-directed insertion deletion mutagenesis 32. Miyakawa, T., H. Matsuzawa, M. Matsuhashi, Y. Sugino.                 cloned fragments Eschenchia coli. J. Bacteriol. 161:1219-
      1972. Cell wall peptidoglycan mutants Escherichia coli K-12:          1221.
      existence clusters genes, mra mrb, cell wall     46. Yanisch-Perron, C., J. Vieira, J. 